Showing 1–12 of 75 results

Show sidebar

AFANIX 40 MG

Afatinib is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose

AXINIX 1 MG

Axinix (Axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one prior

AXINIX 5 MG

DESCRIPTION Axinix (Axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one

BARICINIX 2 MG

Product Description: Baricitinib is indicated for the treatment of moderate to severely active rheumatoid arthritis in adult patients who have

BARICINIX 4 MG

Product Description: Baricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded

CABOZANIX 20 MG

Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and

CABOZANIX 80 MG

Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and

COVIRIN 200MG

Covirin Capsule 200 mg Indications Ribavirin is indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with

CRIZOCENT 250 MG

Presentation Crizocent 250: Each capsule contains Crizotinib INN 250 mg Description Crizotinib is an inhibitor of receptor tyrosine kinases including